Andere Sprachen Aarti Drugs Limited NSE India S.E.

Aktien

A140C3

INE767A01016

AARTIDRUGS

Verzögert NSE India S.E. Andere Börsenplätze 07:11:59 11.06.2024			% 5 Tage	% 1. Jan.
513,1 ^INR	+0,20 %		+7,95 %	+5,11 %

06.05.	Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024
03.05.	Aarti Drugs Limited meldet Ergebnis für das vierte Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	03.05.
Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2024	03.05.
Aarti Drugs Limited Announces Executive Cessation	29.03.
Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility	31.01.
Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra	30.01.
Aarti Drugs Limited Announces Interim Dividend for the Financial Year 2023- 24	24.01.
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24.01.
Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	19.10.23
Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.	28.08.23
Aarti Drugs Limited's Equity Buyback announced on July 21, 2023, has closed with 665,000 shares, representing 0.72% for INR 598.5 million.	17.08.23
Aarti Drugs Clocks Gains in Fiscal Q1 Consolidated Profit	24.07.23
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.	21.07.23
Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	21.07.23
Aarti Drugs Limited authorizes a Buyback Plan.	21.07.23
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	14.07.23
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	14.07.23
Aarti Drugs' Consolidated Profit Climbs in Fiscal Q4	01.05.23
Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29.04.23
Aarti Drugs' Consolidated Net Profit Declines in Fiscal Q3	30.01.23
Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2022-23	27.01.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aarti Drugs Limited NSE India S.E.

Aktien

A140C3

INE767A01016

AARTIDRUGS

Andere Sprachen

Filter